awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27024006-E00E3366-00C3-4901-A3BC-B23C68FE7E95
Q27024006-E00E3366-00C3-4901-A3BC-B23C68FE7E95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27024006-E00E3366-00C3-4901-A3BC-B23C68FE7E95
Progress in acute myeloid leukemia
P2860
Q27024006-E00E3366-00C3-4901-A3BC-B23C68FE7E95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27024006-E00E3366-00C3-4901-A3BC-B23C68FE7E95
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d224256170cfaaa24bf68e8dcf9d325277548d89
P2860
Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study